# Molex agrees to acquire Vectura Group Limited

Molex, through its affiliate Molex Asia Holdings, signed an agreement to purchase Vectura Group Limited from Vectura Fertin Pharma Inc., a subsidiary of Philip Morris International, to expand its drug delivery capabilities in inhalation.

- Type: Acquisition
- Announced: 2024-09-17
- Where: Chippenham, United Kingdom, United Kingdom
- Status: announced
- Products: inhalation drug devices, dry powder inhalers, pressurized metered dose inhalers, nasal and nebulizer products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Vectura AS](https://endata.com/companies/5555.md) (target)
- [Philip Morris International](https://endata.com/companies/14502.md) (investor)
- [Phillips-Medisize Corporation](https://endata.com/companies/20563.md) (partner)
- [Molex](https://endata.com/companies/20564.md) (acquirer)
- [Vectura Fertin Pharma Inc.](https://endata.com/companies/79874.md) (partner)

## Sources

- [drug-dev.com](https://drug-dev.com/molex-announces-agreement-to-acquire-the-vectura-group-limited-expanding-its-drug-delivery-capabilities-in-inhalation/), 2024-09-17: "Combining the strengths of Phillips Medisize and Vectura will enhance our ability to deliver a broader portfolio of inhalation combination drug devices and solutions to our pharmaceutical customers."
- [news.outsourceaccelerator.com](https://news.outsourceaccelerator.com/molex-drug-delivery-vectura-group-acquisition/), 2024-09-23: "Combining the strengths of Phillips Medisize and Vectura will enhance our ability to deliver a broader portfolio of inhalation combination drug devices and solutions to our pharmaceutical customers."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.